TY - JOUR
T1 - NLRC5 deficiency does not influence cytokine induction by virus and bacteria infections
AU - Kumar, Himanshu
AU - Pandey, Surya
AU - Zou, Jian
AU - Kumagai, Yutaro
AU - Takahashi, Ken
AU - Akira, Shizuo
AU - Kawai, Taro
PY - 2011/1/15
Y1 - 2011/1/15
N2 - Nucleotide-binding domain and leucine rich repeat containing gene family receptors (NLRs) are cytosolic proteins that respond to a variety of pathogen and host components to induce inflammatory cytokines. NLRC5 is a recently identified member of the NLR family that has been implicated in positive and negative regulation of antiviral innate immune responses. To clarify whether NLRC5 controls antiviral innate immunity in vivo, we generated NLRC5-deficient mice. Macrophages and dendritic cells derived from NLRC5-deficient mice induced relatively normal levels of IFN-β, IL-6, and TNF-α after treatment with RNA viruses, DNA viruses, and bacteria. The serum cytokine levels after polyinosinic-polycytidylic acid infection were also comparable between control and NLRC5-deficient mice. NLRC5 overexpression promoted IL-1β production via caspase-1, suggesting that NLRC5 constitutes an inflammasome. However, there was no reduction of IL-1β in NLRC5-deficient cells in response to known inflammasome activators, suggesting that NLRC5 controls IL-1β production through an unidentified pathway. These findings indicate that NLRC5 is dispensable for cytokine induction in virus and bacterial infections under physiologic conditions.
AB - Nucleotide-binding domain and leucine rich repeat containing gene family receptors (NLRs) are cytosolic proteins that respond to a variety of pathogen and host components to induce inflammatory cytokines. NLRC5 is a recently identified member of the NLR family that has been implicated in positive and negative regulation of antiviral innate immune responses. To clarify whether NLRC5 controls antiviral innate immunity in vivo, we generated NLRC5-deficient mice. Macrophages and dendritic cells derived from NLRC5-deficient mice induced relatively normal levels of IFN-β, IL-6, and TNF-α after treatment with RNA viruses, DNA viruses, and bacteria. The serum cytokine levels after polyinosinic-polycytidylic acid infection were also comparable between control and NLRC5-deficient mice. NLRC5 overexpression promoted IL-1β production via caspase-1, suggesting that NLRC5 constitutes an inflammasome. However, there was no reduction of IL-1β in NLRC5-deficient cells in response to known inflammasome activators, suggesting that NLRC5 controls IL-1β production through an unidentified pathway. These findings indicate that NLRC5 is dispensable for cytokine induction in virus and bacterial infections under physiologic conditions.
UR - http://www.scopus.com/inward/record.url?scp=78751495854&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78751495854&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1002094
DO - 10.4049/jimmunol.1002094
M3 - Article
C2 - 21148033
AN - SCOPUS:78751495854
SN - 0022-1767
VL - 186
SP - 994
EP - 1000
JO - Journal of Immunology
JF - Journal of Immunology
IS - 2
ER -